Skip to content

Robert Marsh, MD

NPI 1659428019ActiveIndividual· Family Medicine· Minnetonka, MN

Family Medicine (MD) in Minnetonka, Minnesota, licensed in MN, with an NPI issued in January 2007. Takeda Pharmaceuticals U.S.A., Inc. reported $48,925 in payments in 2025, mostly consulting fees.

Overview

NPI1659428019
StatusActive
Entity typeIndividual
CredentialMD
Sole proprietorYes
NPI issuedJan 5, 2007
Last updated in NPPESJul 8, 2007

Specialties and licenses

TaxonomyCodeLicenseState
Family Medicine Primary207Q00000X20813MN

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Not in the public enrollment file of Oct 1, 2026

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$48,925 · 25 payments from 1 company
  • 2024$50,928 · 28 payments from 1 company

Top paying companies in 2025

CompanyAmountPayments
Takeda Pharmaceuticals U.S.A., Inc.$48,92525

What the 2025 payments were for

  • Consulting Fee$48,925 · 25 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other family medicine physicians in Minnetonka

All 31 family medicine physicians in Minnetonka · All family medicine physicians in Minnesota